Terms: = Sarcomas AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Clinical Outcome
58 results:
1. Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies.
Recio F; Scalise CB; Loar P; Lumish M; Berman T; Peddada A; Kalashnikova E; Rivero-Hinojosa S; Beisch T; Nicosia B; Farmer T; Dutta P; Malhotra M; ElNaggar AC; Liu MC; Vaccarello L; Holloway RW
Gynecol Oncol; 2024 Mar; 182():63-69. PubMed ID: 38262240
[TBL] [Abstract] [Full Text] [Related]
2. Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologies.
Dermawan JK; Chi P; Tap WD; Rosenbaum E; D'Angelo S; Alektiar KM; Antonescu CR
J Pathol; 2023 Aug; 260(4):465-477. PubMed ID: 37350195
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive analysis of cell death genes in hepatocellular carcinoma based on multi-omics data.
Zhang L; Chen X; Guo X; Shen H; Qiu D; Jin W; Hou D
Adv Clin Exp Med; 2023 Feb; 32(2):233-244. PubMed ID: 36753369
[TBL] [Abstract] [Full Text] [Related]
4. Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with clinical outcome and Are Detectable in Cell-Free DNA.
Cortes-Ciriano I; Steele CD; Piculell K; Al-Ibraheemi A; Eulo V; Bui MM; Chatzipli A; Dickson BC; Borcherding DC; Feber A; Galor A; Hart J; Jones KB; Jordan JT; Kim RH; Lindsay D; Miller C; Nishida Y; Proszek PZ; Serrano J; Sundby RT; Szymanski JJ; Ullrich NJ; Viskochil D; Wang X; Snuderl M; Park PJ; Flanagan AM; Hirbe AC; Pillay N; Miller DT;
Cancer Discov; 2023 Mar; 13(3):654-671. PubMed ID: 36598417
[TBL] [Abstract] [Full Text] [Related]
5. Extraskeletal myxoid chondrosarcoma: p53 and Ki-67 offer prognostic value for clinical outcome - an immunohistochemical and molecular analysis of 31 cases.
Giner F; López-Guerrero JA; Machado I; Rubio-Martínez LA; Espino M; Navarro S; Agra-Pujol C; Ferrández A; Llombart-Bosch A
Virchows Arch; 2023 Feb; 482(2):407-417. PubMed ID: 36376703
[TBL] [Abstract] [Full Text] [Related]
6. ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis.
Pasello M; Giudice AM; Cristalli C; Manara MC; Mancarella C; Parra A; Serra M; Magagnoli G; Cidre-Aranaz F; Grünewald TGP; Bini C; Lollini PL; Longhi A; Donati DM; Scotlandi K
Cell Oncol (Dordr); 2022 Dec; 45(6):1237-1251. PubMed ID: 36149602
[TBL] [Abstract] [Full Text] [Related]
7. Fusion of the Paired Box 3 (
Panagopoulos I; Gorunova L; Andersen K; Lund-Iversen M; Tafjord S; Micci F; Heim S
Cancer Genomics Proteomics; 2021; 18(6):723-734. PubMed ID: 34697065
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic impact of IDH mutations in chondrosarcoma.
Nakagawa M; Sekimizu M; Endo M; Kobayashi E; Iwata S; Fukushima S; Yoshida A; Kitabayashi I; Ichikawa H; Kawai A; Nakatani F
J Orthop Sci; 2022 Nov; 27(6):1315-1322. PubMed ID: 34531086
[TBL] [Abstract] [Full Text] [Related]
9. Genomic Classification and clinical outcome in Rhabdomyosarcoma: A Report From an International Consortium.
Shern JF; Selfe J; Izquierdo E; Patidar R; Chou HC; Song YK; Yohe ME; Sindiri S; Wei J; Wen X; Rudzinski ER; Barkauskas DA; Lo T; Hall D; Linardic CM; Hughes D; Jamal S; Jenney M; Chisholm J; Brown R; Jones K; Hicks B; Angelini P; George S; Chesler L; Hubank M; Kelsey A; Gatz SA; Skapek SX; Hawkins DS; Shipley JM; Khan J
J Clin Oncol; 2021 Sep; 39(26):2859-2871. PubMed ID: 34166060
[TBL] [Abstract] [Full Text] [Related]
10. Tumor-Associated Antigens (TAAs) for the Serological Diagnosis of Osteosarcoma.
Li J; Qin B; Huang M; Ma Y; Li D; Li W; Guo Z
Front Immunol; 2021; 12():665106. PubMed ID: 33995397
[TBL] [Abstract] [Full Text] [Related]
11. Identified a disintegrin and metalloproteinase with thrombospondin motifs 6 serve as a novel gastric cancer prognostic biomarker by bioinformatics analysis.
Zhu YZ; Liu Y; Liao XW; Luo SS
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33851708
[TBL] [Abstract] [Full Text] [Related]
12. Corded and Hyalinized Endometrioid Adenocarcinoma (CHEC) of the Uterine Corpus are Characterized by CTNNB1 Mutations and Can Show Adverse clinical outcomes.
Ladwig NR; Umetsu SE; Zaloudek C; Rabban J; Garg K
Int J Gynecol Pathol; 2021 Mar; 40(2):103-115. PubMed ID: 32909971
[TBL] [Abstract] [Full Text] [Related]
13. Genomic Profiling Identifies Association of
Zhu GG; Nafa K; Agaram N; Zehir A; Benayed R; Sadowska J; Borsu L; Kelly C; Tap WD; Fabbri N; Athanasian E; Boland PJ; Healey JH; Berger MF; Ladanyi M; Hameed M
Clin Cancer Res; 2020 Jan; 26(2):419-427. PubMed ID: 31615936
[TBL] [Abstract] [Full Text] [Related]
14. DICER1 mutations are frequent in müllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation.
Bean GR; Anderson J; Sangoi AR; Krings G; Garg K
Mod Pathol; 2019 Feb; 32(2):280-289. PubMed ID: 30266945
[TBL] [Abstract] [Full Text] [Related]
15. Effect of lutein and doxorubicin combinatorial therapy on S180 cell proliferation and tumor growth.
Luan RL; Wang PC; Yan MX; Chen J
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1514-1520. PubMed ID: 29565515
[TBL] [Abstract] [Full Text] [Related]
16. Genome-wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma.
Smida J; Xu H; Zhang Y; Baumhoer D; Ribi S; Kovac M; von Luettichau I; Bielack S; O'Leary VB; Leib-Mösch C; Frishman D; Nathrath M
Int J Cancer; 2017 Aug; 141(4):816-828. PubMed ID: 28494505
[TBL] [Abstract] [Full Text] [Related]
17. tp53 Mutations and Survival in Osteosarcoma Patients: A Meta-Analysis of Published Data.
Chen Z; Guo J; Zhang K; Guo Y
Dis Markers; 2016; 2016():4639575. PubMed ID: 27239089
[TBL] [Abstract] [Full Text] [Related]
18. Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue sarcomas: A Spanish Group for Research on Sarcoma Study.
Martin-Broto J; Pousa AL; de Las Peñas R; García Del Muro X; Gutierrez A; Martinez-Trufero J; Cruz J; Alvarez R; Cubedo R; Redondo A; Maurel J; Carrasco JA; López-Martin JA; Sala Á; Meana JA; Ramos R; Martinez-Serra J; Lopez-Guerrero JA; Sevilla I; Balaña C; Vaz Á; De Juan A; Alemany R; Poveda A
J Clin Oncol; 2016 Jul; 34(19):2294-302. PubMed ID: 27185843
[TBL] [Abstract] [Full Text] [Related]
19. Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in tp53, ATRX, and MED12.
Mäkinen N; Aavikko M; Heikkinen T; Taipale M; Taipale J; Koivisto-Korander R; Bützow R; Vahteristo P
PLoS Genet; 2016 Feb; 12(2):e1005850. PubMed ID: 26891131
[TBL] [Abstract] [Full Text] [Related]
20. Retrospective Multicenter Study Investigating the Role of Targeted Next-Generation Sequencing of Selected Cancer Genes in Mucinous Adenocarcinoma of the Lung.
Righi L; Vatrano S; Di Nicolantonio F; Massa F; Rossi G; Cavazza A; Volante M; Votta A; Izzo S; Lo Iacono M; Ardissone F; Di Maio M; Novello S; Scagliotti GV; Papotti M
J Thorac Oncol; 2016 Apr; 11(4):504-15. PubMed ID: 26774193
[TBL] [Abstract] [Full Text] [Related]
[Next]
